Profile data is unavailable for this security.
About the company
Cisen Pharmaceutical Co., Ltd is a China-based company principally involved in the research, development, manufacturing and sales of medical products. The Company operates through two main segments. The Main Business segment is primarily involved in the manufacturing and sales of medicine, among which include infusion, freeze-dried powder, small volume injection, tablet, capsules, ointment, drops and active pharmaceutical ingredients, among others. The Other Business segment is mainly involved in the sales of raw materials and houses tenancy.
- Revenue in CNY (TTM)3.56bn
- Net income in CNY492.80m
- Incorporated1998
- Employees3.30k
- LocationCisen Pharmaceutical Co LtdNo.16 Tongji Road, Hi-tech ZoneJINING 272073ChinaCHN
- Phone+86 5 372989906
- Fax+86 5 372215851
- Websitehttp://www.cisen-pharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wuhan Keqian Biology Co Ltd | 1.01bn | 459.54m | 7.64bn | 924.00 | 16.74 | 1.83 | -- | 7.54 | 0.9796 | 0.9796 | 2.16 | 8.95 | 0.2209 | 2.86 | 3.23 | 1,097,706.00 | 9.97 | 11.71 | 11.17 | 13.56 | 65.26 | 73.57 | 45.16 | 44.51 | 5.02 | -- | 0.0017 | 32.23 | -11.48 | 13.17 | -3.43 | 9.52 | -4.93 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 3.78bn | 214.11m | 7.72bn | 3.63k | 35.95 | 1.84 | -- | 2.04 | 0.2112 | 0.2112 | 3.72 | 4.12 | 0.633 | 3.37 | 7.63 | 1,040,448.00 | 4.45 | 0.7994 | 6.29 | 5.29 | 51.41 | 23.96 | 7.02 | 3.71 | 3.96 | -- | 0.0393 | 43.21 | -13.02 | -17.29 | -19.73 | -6.70 | 21.16 | 0.00 |
| Heilongjiang ZBD Pharmaceutical Co Ltd | 1.60bn | -332.62m | 7.89bn | 2.35k | -- | 1.08 | -- | 4.95 | -0.3545 | -0.3545 | 1.70 | 7.75 | 0.1303 | 0.6358 | 0.4977 | 679,399.90 | -2.74 | 3.29 | -3.80 | 4.46 | 44.16 | 37.24 | -21.03 | 10.59 | 1.33 | -1.45 | 0.3114 | 24.43 | -13.90 | -3.87 | -7.30 | 1.41 | 1.13 | -7.12 |
| Cisen Pharmaceutical Co Ltd | 3.56bn | 492.80m | 7.96bn | 3.30k | 16.21 | 1.29 | -- | 2.23 | 1.08 | 1.08 | 7.84 | 13.59 | 0.472 | 2.10 | 5.34 | 1,079,074.00 | 6.58 | 6.51 | 8.12 | 8.07 | 53.70 | 55.92 | 13.94 | 10.84 | 3.48 | -- | 0.0069 | 37.16 | -10.77 | -0.6464 | -2.38 | -0.2215 | -0.3051 | 10.42 |
| China Animal Husbandry Industry Co., Ltd | 6.28bn | 214.44m | 7.98bn | 4.30k | 37.19 | 1.39 | -- | 1.27 | 0.21 | 0.21 | 6.15 | 5.60 | 0.6863 | 5.30 | 4.19 | 1,461,064.00 | 2.32 | 5.25 | 3.37 | 7.48 | 15.59 | 22.15 | 3.38 | 7.31 | 1.62 | -- | 0.1625 | 31.16 | 11.30 | 7.79 | -82.41 | -22.24 | -0.0699 | -21.83 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 751.12m | 184.84m | 8.20bn | 1.22k | 44.04 | 3.49 | -- | 10.91 | 0.2241 | 0.2241 | 0.8963 | 2.83 | 0.2472 | 0.9248 | 3.00 | 616,180.10 | 6.08 | 8.91 | 7.77 | 12.10 | 51.51 | 53.44 | 24.61 | 27.68 | 2.17 | -- | 0.1383 | 27.35 | -2.63 | 20.90 | -18.55 | 29.68 | 17.53 | 43.79 |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 2.29bn | -363.56m | 8.22bn | 2.97k | -- | 1.42 | -- | 3.58 | -0.1112 | -0.1112 | 0.7189 | 1.82 | 0.204 | 2.09 | 3.30 | 771,487.60 | -4.90 | -0.1745 | -7.79 | -0.2739 | 34.13 | 64.36 | -24.05 | -0.6631 | 2.01 | -5.26 | 0.2563 | 69.54 | -26.67 | -9.85 | -547.14 | -- | 4.41 | -- |
Data as of Feb 11 2026. Currency figures normalised to Cisen Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 2.24m | 0.50% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2025 | 2.01m | 0.45% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 1.32m | 0.29% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 990.20k | 0.22% |
| First-Trust Fund Management Co., Ltd.as of 30 Jun 2025 | 420.00k | 0.09% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 239.40k | 0.05% |
| Arrowstreet Capital LPas of 31 Jan 2026 | 235.60k | 0.05% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 173.40k | 0.04% |
| Galaxy Asset Management Co., Ltd.as of 30 Jun 2025 | 171.70k | 0.04% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2025 | 170.40k | 0.04% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
